data_5x38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x38 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.625 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.479 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.496 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' C ' HD21 ' A' ' 29' ' ' ASN . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.532 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.44 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.9 t-160 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.42 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.657 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.502 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 12.3 t-160 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.774 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.756 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.536 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.536 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.815 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.471 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.815 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.43 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.643 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.566 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.771 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.451 HD13 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.471 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.7 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.685 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.436 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.522 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.9 t-160 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HH ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD2' ' HH ' ' A' ' 13' ' ' TYR . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.63 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.414 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.5 tp-100 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.624 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.481 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.87 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.87 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.554 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.528 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.438 ' C ' HD21 ' A' ' 29' ' ' ASN . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.438 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.629 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.789 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.474 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 34' ' ' GLN . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.555 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.662 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.422 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.625 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.662 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.698 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.417 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.479 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.698 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.719 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.41 ' H ' ' H1 ' ' A' ' 101' ' ' BGC . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.857 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' C ' HD21 ' A' ' 29' ' ' ASN . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.532 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.719 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.707 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.415 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.44 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.9 t-160 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.657 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.707 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.689 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.442 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 12.3 t-160 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.774 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.689 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.803 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.423 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.536 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.536 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.803 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.735 ' OE1' ' H1 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.431 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.815 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.471 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.815 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.735 ' H1 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.684 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.43 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.643 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.566 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.771 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.684 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.731 ' OE1' ' H1 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.419 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.451 HD13 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.471 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.731 ' H1 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.813 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.417 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.7 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.685 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.813 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.748 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.409 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.522 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.9 t-160 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HH ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD2' ' HH ' ' A' ' 13' ' ' TYR . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.63 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.748 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.714 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.445 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.649 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.624 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.481 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.714 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.694 ' OE1' ' H1 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.87 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.87 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.694 ' H1 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.856 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.403 ' H ' ' H1 ' ' A' ' 101' ' ' BGC . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.856 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.783 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' N ' ' H1 ' ' A' ' 101' ' ' BGC . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.554 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.783 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.917 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.432 ' N ' ' H1 ' ' A' ' 101' ' ' BGC . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.438 ' C ' HD21 ' A' ' 29' ' ' ASN . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.438 HD21 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.917 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.744 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.629 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.744 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.732 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.424 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.789 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.732 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.726 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.411 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.474 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.726 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.689 ' OE1' ' H1 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.427 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' HA ' ' CG ' ' A' ' 34' ' ' GLN . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.555 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' BGC . . . . . 0.689 ' H1 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.637 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.869 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA3' ' A' ' 9' ' ' GLY . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 32' ' ' TYR . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' A' ' 28' ' ' LEU . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.869 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.844 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.67 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.844 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.462 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 1.1 t60 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 13' ' ' TYR . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.55 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.55 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.832 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 28' ' ' LEU . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.527 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 34' ' ' GLN . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 5' ' ' TYR . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 HG22 ' HA3' ' A' ' 9' ' ' GLY . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.6 m-20 -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE2' HD12 ' A' ' 28' ' ' LEU . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.883 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.457 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' HA3' ' A' ' 9' ' ' GLY . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 17.6 m120 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 32' ' ' TYR . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE1' HD12 ' A' ' 28' ' ' LEU . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.846 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.623 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.846 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.481 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.9 m-20 -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.615 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.637 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.615 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.656 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.656 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.671 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.472 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.869 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA3' ' A' ' 9' ' ' GLY . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 32' ' ' TYR . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.1 m-20 -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' A' ' 28' ' ' LEU . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.869 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.671 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.671 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.494 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.844 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.67 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.844 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.671 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.644 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.526 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.462 ' CE1' ' O ' ' A' ' 36' ' ' LEU . 1.1 t60 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 13' ' ' TYR . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' O ' ' CE1' ' A' ' 4' ' ' HIS . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.644 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.773 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.505 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.55 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.55 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.773 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.511 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.832 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.584 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.647 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.479 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.647 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.606 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.503 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 28' ' ' LEU . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.606 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.802 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.512 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 34' ' ' GLN . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 5' ' ' TYR . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.802 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.73 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.491 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 HG22 ' HA3' ' A' ' 9' ' ' GLY . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.73 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.684 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.522 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 2.6 m-20 -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE2' HD12 ' A' ' 28' ' ' LEU . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.684 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.883 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.59 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.82 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.453 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.82 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.759 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.511 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.457 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' HA3' ' A' ' 9' ' ' GLY . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 17.6 m120 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.759 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.9 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.499 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 32' ' ' TYR . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE1' HD12 ' A' ' 28' ' ' LEU . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.9 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.696 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.459 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.846 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.623 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.846 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.696 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.721 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.721 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.678 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.629 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 1.9 m-20 -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' BGC . . . . . 0.629 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 32' ' ' TYR . 36.4 m-80 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.637 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.869 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA3' ' A' ' 9' ' ' GLY . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD22 ' A' ' 29' ' ' ASN . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.486 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' A' ' 28' ' ' LEU . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.869 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.439 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.9 t-160 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.844 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.67 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.844 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 12.3 t-160 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 13' ' ' TYR . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.406 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.55 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.55 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.832 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.48 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 28' ' ' LEU . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.527 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 34' ' ' GLN . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 5' ' ' TYR . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.447 ' OE1' ' HA3' ' A' ' 6' ' ' GLY . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.522 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.9 t-160 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 HG22 ' HA3' ' A' ' 9' ' ' GLY . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.408 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.5 tp-100 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE2' HD12 ' A' ' 28' ' ' LEU . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.883 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.457 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' HA3' ' A' ' 9' ' ' GLY . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 32.3 m-80 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD22 ' A' ' 29' ' ' ASN . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.481 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE1' HD12 ' A' ' 28' ' ' LEU . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.846 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.623 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.846 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.481 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.615 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.3 tp-100 -68.48 127.27 32.37 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.171 0.588 . . . . 0.0 110.888 -174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.3 p -74.77 170.93 14.89 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.505 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.88 133.17 54.28 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.667 0.787 . . . . 0.0 109.272 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 78.59 5.33 2.51 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.057 1.343 . . . . 0.0 112.985 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.13 160.27 30.69 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.122 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.6 tt0 -78.42 112.72 15.74 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -90.51 4.48 51.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.15 91.11 0.86 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 117.968 -2.063 . . . . 0.0 114.282 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.64 -174.87 30.99 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.93 117.17 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 117.766 0.783 . . . . 0.0 110.626 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.9 -14.1 66.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.914 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -82.22 104.66 12.7 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 117.622 0.711 . . . . 0.0 109.897 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -101.72 16.44 25.8 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.546 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.74 -151.93 15.22 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.61 115.94 2.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.546 2.164 . . . . 0.0 111.995 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -107.1 -28.28 10.08 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.13 127.09 42.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.7 m -84.78 159.89 20.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.463 0.477 . . . . 0.0 110.815 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 146.29 41.3 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.855 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -58.24 117.19 4.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.101 0.477 . . . . 0.0 110.838 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.21 -21.99 10.6 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.2 p -108.88 142.12 39.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -117.76 141.06 48.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.29 114.55 9.46 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -105.6 111.74 24.55 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.428 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.44 98.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -83.63 -39.8 19.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.671 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 32' ' ' TYR . 36.4 m-80 -140.5 167.23 18.54 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.37 -42.18 67.34 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.331 2.02 . . . . 0.0 112.799 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.637 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 37.3 m-85 -99.88 -27.02 13.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.459 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.0 t80 -96.66 115.6 27.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.4 m -124.53 136.42 53.97 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.7 tt0 -128.25 139.51 52.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.477 0.58 . . . . 0.0 111.682 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.802 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.3 m -78.32 115.95 18.4 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.297 -1.686 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.644 178.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.615 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 24.8 m . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.656 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -102.12 126.54 49.1 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 123.074 0.55 . . . . 0.0 109.638 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 79.6 p -70.99 174.71 5.86 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.373 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -66.55 132.5 48.34 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 78.91 7.87 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.992 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.09 154.41 24.43 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.975 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.3 tt0 -78.57 109.89 13.18 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.8 p -69.03 -42.14 76.75 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.861 0.838 . . . . 0.0 109.123 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.16 117.17 0.77 Allowed Glycine 1 N--CA 1.396 -4.006 0 C-N-CA 119.563 -1.303 . . . . 0.0 112.729 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.79 -160.78 29.78 Favored Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.86 120.27 2.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 117.259 0.53 . . . . 0.0 110.544 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.53 -18.62 56.69 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.408 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -99.66 115.65 29.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -132.0 29.68 4.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.68 -121.47 0.82 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.566 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 32.0 Cg_endo -67.21 79.19 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.983 2.455 . . . . 0.0 112.049 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 p -90.09 -19.99 23.69 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.796 0.839 . . . . 0.0 112.655 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' THR . 60.7 t -88.44 114.82 27.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 62.3 m -77.1 149.26 35.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.99 142.81 45.33 Favored 'General case' 0 C--O 1.249 1.06 0 O-C-N 123.739 0.649 . . . . 0.0 109.958 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.3 m -53.82 116.44 2.53 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.575 0.75 . . . . 0.0 110.659 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.56 7.83 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 p -109.38 151.72 26.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 p -129.87 131.23 46.01 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 122.826 0.45 . . . . 0.0 110.484 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.6 t -74.31 113.98 12.15 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.501 0.667 . . . . 0.0 110.622 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -97.01 121.31 38.75 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.632 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.64 94.86 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.79 -33.02 31.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.945 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -144.67 166.84 16.67 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.62 -41.01 82.02 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.542 2.161 . . . . 0.0 113.258 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 58.5 m-85 -104.02 -26.41 12.62 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.555 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -94.46 114.57 26.6 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.52 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 32.6 m -132.8 126.16 31.7 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -121.71 134.13 54.95 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 57.3 m -73.39 107.7 5.83 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.421 -1.923 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.656 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.671 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.88 129.53 37.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.006 0.432 . . . . 0.0 110.188 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.472 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 60.7 p -81.4 176.64 9.54 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.098 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 13.4 t-160 -65.96 127.55 32.5 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 82.9 1.08 1.17 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.925 1.29 . . . . 0.0 113.606 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -82.15 165.42 45.14 Favored Glycine 0 C--O 1.251 1.209 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.346 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -81.67 109.83 16.45 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.869 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.8 p -89.16 8.52 29.64 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -173.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 116.03 98.19 2.1 Favored Glycine 0 CA--C 1.485 -1.825 0 C-N-CA 117.934 -2.079 . . . . 0.0 114.426 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.55 -168.67 30.03 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 172.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 80.3 mt -58.94 113.58 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 117.464 0.632 . . . . 0.0 111.06 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 2.3 76.9 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.653 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 28.5 t80 -105.67 104.78 14.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 p -117.36 13.71 14.57 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.6 -125.99 0.32 Allowed Glycine 0 C--O 1.244 0.737 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.675 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.0 96.26 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.424 2.083 . . . . 0.0 110.453 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA3' ' A' ' 9' ' ' GLY . 5.6 p -115.11 -25.79 7.96 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.933 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.41 114.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 64.6 m -76.93 145.25 38.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.599 0.562 . . . . 0.0 110.231 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.4 158.28 14.98 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.315 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.9 p -57.61 114.03 2.07 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.369 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.42 -2.91 23.57 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.031 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 74.2 p -127.59 146.59 50.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.276 -0.543 . . . . 0.0 110.651 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 p -118.82 143.25 47.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -78.71 104.48 9.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.428 0.632 . . . . 0.0 110.579 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -100.76 114.11 27.59 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.56 106.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD22 ' A' ' 29' ' ' ASN . 66.2 mt -88.9 -44.0 10.77 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.813 . . . . 0.0 109.712 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.486 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -128.85 165.05 34.57 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.23 -39.13 93.24 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.918 1.746 . . . . 0.0 112.93 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.7 m-85 -104.04 -25.64 12.91 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.796 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' A' ' 28' ' ' LEU . 62.5 t80 -95.48 114.65 26.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.9 m -123.19 146.24 47.96 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.4 tt0 -135.93 135.45 39.64 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.625 0.648 . . . . 0.0 111.983 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.869 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.7 m -76.32 112.78 13.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 123.348 0.659 . . . . 0.0 109.391 179.461 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.671 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.671 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -80.96 121.99 26.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.494 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 72.9 p -72.21 163.28 28.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.362 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.439 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 20.9 t-160 -59.53 133.17 55.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 81.2 1.37 1.65 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.758 1.223 . . . . 0.0 112.796 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.84 161.77 36.74 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.9 tt0 -79.03 109.01 12.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.844 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.8 p -84.05 14.18 4.4 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.84 87.38 1.38 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 118.638 -1.744 . . . . 0.0 113.189 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.53 -176.52 29.88 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 30' ' ' PRO . 69.3 mt -60.61 116.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 117.388 0.594 . . . . 0.0 109.858 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.82 -12.21 62.59 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.711 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -100.46 104.94 16.36 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -110.11 11.55 23.75 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.341 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.73 -144.8 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.503 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 24.7 Cg_endo -62.58 103.64 0.33 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.353 2.036 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.6 p -97.35 -31.79 12.21 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.332 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.81 114.83 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.868 0.366 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -76.01 149.08 37.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 157.9 5.79 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 123.686 0.794 . . . . 0.0 111.957 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.54 112.21 1.52 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.938 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.94 -9.36 27.43 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.023 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.3 p -117.12 145.93 43.48 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 p -123.61 149.6 45.15 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 121.42 -0.112 . . . . 0.0 110.734 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.55 110.99 10.39 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.284 0.564 . . . . 0.0 110.986 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -100.82 109.09 21.04 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.4 t -80.76 101.81 6.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 32' ' ' TYR . 83.9 mt -84.26 -46.9 11.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.65 -175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -132.63 167.53 22.23 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' O ' HG13 ' A' ' 11' ' ' ILE . 76.8 Cg_exo -55.05 -43.51 58.6 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.938 1.759 . . . . 0.0 112.65 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.67 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 44.2 m-85 -98.9 -27.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.335 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 28' ' ' LEU . 39.2 t80 -96.06 114.59 26.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -126.68 140.92 52.04 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 33.8 tt0 -134.65 138.94 44.9 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 119.24 0.927 . . . . 0.0 111.861 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.844 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.2 m -77.26 115.06 16.72 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 120.804 0.335 . . . . 0.0 110.811 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.671 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.439 -1.023 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.644 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -99.68 129.87 45.85 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.526 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 95.8 p -69.61 167.16 17.48 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.6 0.714 . . . . 0.0 112.803 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 12.3 t-160 -63.84 132.69 51.61 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 77.05 7.33 3.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.79 1.236 . . . . 0.0 112.783 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.48 21.41 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' SER . 57.4 tt0 -69.61 112.16 5.91 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -74.04 -55.51 6.03 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 123.746 0.654 . . . . 0.0 111.972 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.33 94.25 0.13 Allowed Glycine 0 CA--C 1.471 -2.673 0 C-N-CA 119.059 -1.543 . . . . 0.0 112.151 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 13' ' ' TYR . . . -97.97 155.3 20.36 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.16 109.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.34 3.02 53.94 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.733 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 92.4 t80 -107.18 126.05 51.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -120.13 23.51 10.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.293 0.568 . . . . 0.0 111.704 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 -164.95 19.53 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 18.7 Cg_endo -63.33 108.93 0.89 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.162 1.908 . . . . 0.0 111.433 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 35.9 p -88.5 -29.72 19.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.9 t -80.81 114.77 22.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.8 m -72.58 154.93 40.54 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.802 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.16 142.43 47.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.852 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -55.68 111.7 0.97 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.084 0.554 . . . . 0.0 110.517 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.66 -14.76 9.84 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.8 p -116.25 143.73 45.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 p -116.64 139.93 49.97 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.0 t -73.38 105.19 4.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -104.08 115.5 30.54 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.32 104.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.66 -44.2 10.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.411 0.624 . . . . 0.0 109.815 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.61 164.61 25.5 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -56.56 -28.36 73.89 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.444 2.096 . . . . 0.0 113.63 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -116.43 -23.87 8.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.75 0.31 . . . . 0.0 111.625 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 70.7 t80 -94.59 119.45 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.209 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 17.0 m -125.99 138.94 53.78 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.1 tt0 -130.69 141.16 50.39 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 118.071 0.396 . . . . 0.0 111.447 -173.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.66 115.19 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.406 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.6 mt . . . . . 0 C--N 1.29 -1.989 0 C-N-CA 123.642 0.777 . . . . 0.0 109.409 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.644 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.773 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -71.78 127.83 33.81 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.505 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 54.7 p -80.52 -179.54 7.23 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.765 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -71.11 132.08 44.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 79.85 6.51 1.81 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.628 1.171 . . . . 0.0 112.89 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.21 154.97 25.81 Favored Glycine 0 C--O 1.248 1.019 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -78.13 106.33 9.94 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -69.41 -42.64 74.8 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.43 105.91 0.22 Allowed Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 118.027 -2.035 . . . . 0.0 114.038 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.08 -170.98 29.77 Favored Glycine 0 C--N 1.294 -1.783 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 171.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.36 114.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 117.524 0.662 . . . . 0.0 110.387 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.51 -31.96 8.12 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.666 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -74.94 111.45 10.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.2 m -119.66 32.55 6.02 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.257 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.5 -136.8 7.67 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.078 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.7 98.25 0.35 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.418 2.078 . . . . 0.0 111.174 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.1 p -91.81 -32.62 15.28 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.94 127.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.019 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.8 m -86.38 149.07 25.27 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.976 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.34 154.01 21.28 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 122.861 0.465 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -57.18 115.0 2.4 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.056 0.543 . . . . 0.0 110.348 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.97 12.85 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.55 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 73.1 p -125.74 149.55 48.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -130.63 145.08 51.82 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.847 -0.161 . . . . 0.0 110.765 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.1 t -68.78 108.66 3.51 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.005 0.431 . . . . 0.0 110.332 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -96.11 113.2 24.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.2 t -75.9 97.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 32' ' ' TYR . 93.8 mt -78.11 -41.5 34.91 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.36 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -142.28 164.19 34.95 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.07 -38.69 80.77 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.375 2.05 . . . . 0.0 113.63 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.1 m-85 -102.57 -27.08 12.96 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 28' ' ' LEU . 46.3 t80 -97.18 114.73 26.47 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.25 143.2 51.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -135.34 138.5 43.44 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 118.565 0.62 . . . . 0.0 111.554 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.1 m -74.83 110.47 9.15 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 120.97 0.414 . . . . 0.0 111.057 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.55 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 93.5 mt . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.773 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -101.2 127.46 47.76 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.981 -0.449 . . . . 0.0 109.849 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.511 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 91.6 p -70.16 164.12 24.87 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.822 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -62.23 130.4 45.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 79.09 4.06 2.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.003 1.321 . . . . 0.0 112.744 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -84.67 165.12 40.08 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.6 tt0 -82.61 105.4 13.62 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-O 120.885 0.374 . . . . 0.0 110.003 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.832 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 24.5 p -80.19 13.44 2.33 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.65 96.82 2.43 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.329 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.99 -165.57 29.04 Favored Glycine 0 C--N 1.298 -1.58 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -65.06 123.17 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.85 11.49 70.43 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.723 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -116.64 107.2 14.4 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -112.18 17.68 19.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.139 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.25 -143.88 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.57 -0.572 . . . . 0.0 111.691 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.41 104.94 0.32 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.522 2.148 . . . . 0.0 112.521 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -101.44 -45.22 5.38 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.087 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -70.32 114.89 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.478 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.2 m -74.72 159.23 32.29 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.65 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.49 156.84 21.76 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.116 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -60.81 116.73 4.65 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 122.878 0.471 . . . . 0.0 110.006 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.03 -7.24 31.03 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.834 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.5 p -117.03 147.37 42.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -123.61 136.1 54.32 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -69.81 111.22 5.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.123 0.487 . . . . 0.0 111.502 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -106.68 116.11 31.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.7 t -80.08 108.26 13.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 32' ' ' TYR . 84.7 mt -88.9 -60.35 1.98 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.298 -176.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.48 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -114.04 168.08 8.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.86 -39.31 90.76 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 121.96 1.773 . . . . 0.0 113.409 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 38.2 m-85 -105.59 -25.37 12.3 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.13 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 28' ' ' LEU . 54.9 t80 -94.71 114.48 26.41 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.407 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -124.05 145.98 48.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.5 tt0 -134.89 137.32 43.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 118.921 0.782 . . . . 0.0 112.008 -175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.2 m -77.93 113.97 16.34 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.283 -2.322 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.584 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.647 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -73.04 125.02 26.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.196 0.522 . . . . 0.0 110.49 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.479 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 59.2 p -79.07 178.52 7.98 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.331 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 9.2 t-160 -68.6 132.0 46.18 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 82.65 0.76 1.26 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 112.946 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -83.82 163.36 40.09 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.993 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' SER . 47.1 tt0 -80.86 108.82 14.85 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.0 p -86.89 17.69 3.93 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.97 97.12 2.43 Favored Glycine 0 CA--C 1.491 -1.408 0 C-N-CA 119.107 -1.52 . . . . 0.0 114.236 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.28 -167.58 28.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 172.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 30' ' ' PRO . 74.9 mt -60.97 112.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.56 1.4 66.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.23 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -112.09 104.88 13.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.139 0.969 . . . . 0.0 110.105 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -108.83 28.35 8.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.351 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.81 -140.97 3.35 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.9 97.0 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.786 1.658 . . . . 0.0 110.746 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -105.12 -7.93 18.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.65 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.92 119.0 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.98 151.66 29.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.417 0.448 . . . . 0.0 110.95 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 151.58 37.11 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.324 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -58.52 113.65 2.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.991 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.47 -11.41 11.32 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.855 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -120.04 156.55 30.72 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p -128.07 142.31 51.25 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.557 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -72.09 114.19 9.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.893 0.377 . . . . 0.0 110.021 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 12.4 mm-40 -113.04 129.32 56.54 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -91.67 103.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.52 -37.68 19.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.466 0.65 . . . . 0.0 110.389 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -137.36 164.74 39.6 Favored Pre-proline 0 C--N 1.295 -1.791 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 53.7 Cg_exo -55.14 -43.43 59.14 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.013 1.809 . . . . 0.0 112.645 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 22.1 m-85 -98.69 -25.93 14.53 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -95.48 113.98 25.69 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.566 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.9 m -117.44 147.2 42.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 29.9 tt0 -140.43 136.78 33.4 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 118.998 0.817 . . . . 0.0 111.568 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 53.0 m -78.79 117.39 19.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.598 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 95.7 mt . . . . . 0 C--N 1.293 -1.852 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.647 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.606 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -68.62 127.01 31.5 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.766 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.503 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 82.6 p -75.08 171.9 13.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.197 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -61.14 132.09 52.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.565 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 77.79 0.63 2.82 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.73 1.212 . . . . 0.0 112.573 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.0 158.62 36.72 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.306 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.9 tt0 -83.33 106.07 14.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -68.91 -43.41 75.26 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.264 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 158.14 104.7 0.21 Allowed Glycine 0 N--CA 1.419 -2.489 0 C-N-CA 117.634 -2.222 . . . . 0.0 114.231 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.35 -168.5 29.04 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.1 114.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.25 3.74 50.76 Favored Glycine 0 C--N 1.31 -0.91 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.591 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 32.9 t80 -116.56 125.09 51.37 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 p -131.46 23.79 4.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.043 0.449 . . . . 0.0 111.693 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.47 -130.47 3.15 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 38.7 Cg_endo -69.28 93.86 0.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.201 1.934 . . . . 0.0 111.299 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 19.7 p -89.62 -35.97 15.55 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.942 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -79.12 119.08 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.87 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.8 m -75.74 156.21 34.86 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.655 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 155.34 39.39 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.342 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -56.7 114.6 2.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.478 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.81 -18.36 9.16 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.543 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 67.3 p -115.26 146.53 41.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.296 -0.532 . . . . 0.0 110.713 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 p -118.5 138.56 52.42 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.0 101.9 2.3 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.127 0.489 . . . . 0.0 110.014 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -90.65 115.7 27.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.572 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.42 100.87 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 32' ' ' TYR . 90.8 mt -83.92 -43.73 14.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.97 0.89 . . . . 0.0 109.201 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -136.83 163.96 45.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.71 -34.63 98.46 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.992 1.795 . . . . 0.0 112.975 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.9 m-85 -105.03 -26.55 12.09 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.2 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 28' ' ' LEU . 45.1 t80 -96.76 114.16 25.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.0 m -124.85 142.47 51.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -136.04 135.51 39.49 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.453 0.57 . . . . 0.0 111.862 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.4 m -76.98 112.83 14.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.823 0.344 . . . . 0.0 110.918 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.472 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.606 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.802 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.0 tp60 -74.86 118.64 18.05 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.586 0.708 . . . . 0.0 110.879 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.512 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 86.7 p -67.5 168.78 10.29 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.9 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -62.71 132.2 51.49 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.844 0.858 . . . . 0.0 109.016 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.426 ' HA ' ' HG3' ' A' ' 34' ' ' GLN . 88.8 m-85 75.55 7.27 3.93 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.868 1.267 . . . . 0.0 112.691 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.58 155.16 31.92 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.0 tt0 -76.13 111.36 11.45 Favored 'General case' 0 C--O 1.206 -1.195 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.7 p -87.15 8.31 24.34 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.44 87.16 0.79 Allowed Glycine 0 C--N 1.299 -1.516 0 C-N-CA 118.256 -1.926 . . . . 0.0 113.374 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.0 -179.33 30.34 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.65 117.16 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.94 -16.32 55.96 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.625 -0.797 . . . . 0.0 113.14 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -89.9 129.38 36.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 p -130.93 2.83 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.16 -134.45 1.28 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.57 110.16 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.551 2.167 . . . . 0.0 112.27 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -112.8 -23.85 9.91 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -91.14 115.43 30.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.25 159.83 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.586 0.554 . . . . 0.0 111.589 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.78 155.94 38.14 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.327 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -59.05 114.88 2.8 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.71 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.68 -20.63 10.88 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.7 p -110.69 147.05 35.15 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 122.663 -0.316 . . . . 0.0 110.289 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 p -118.54 139.3 51.68 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.087 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.71 108.18 3.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.998 0.428 . . . . 0.0 110.154 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.38 117.74 35.37 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.6 t -77.39 101.01 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.52 -40.58 19.0 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.309 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -141.91 168.37 13.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.37 -43.48 57.04 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.453 2.102 . . . . 0.0 112.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 63.7 m-85 -100.91 -27.0 13.55 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.762 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -95.52 114.88 26.69 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.156 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 25.1 m -121.81 140.82 51.88 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 5' ' ' TYR . 34.4 tt0 -134.61 134.57 41.4 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.68 0.673 . . . . 0.0 111.504 -173.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.4 m -76.02 117.21 17.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.546 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.802 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.73 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -75.66 124.41 27.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.491 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 52.9 p -80.26 172.89 13.18 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.405 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.522 ' HD2' ' O ' ' A' ' 35' ' ' CYS . 17.9 t-160 -61.95 132.42 52.92 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.649 0.78 . . . . 0.0 109.058 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 79.36 4.63 2.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.0 113.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -86.0 164.0 36.78 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' SER . 48.7 tt0 -83.97 107.2 16.2 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -85.37 11.04 11.06 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 112.19 99.84 2.47 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 118.453 -1.832 . . . . 0.0 113.85 176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.98 -173.25 31.63 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 107.476 -2.25 . . . . 0.0 107.476 171.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.7 117.69 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 117.746 0.773 . . . . 0.0 110.542 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.17 -24.84 25.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.502 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -82.67 111.48 18.66 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -118.02 20.36 13.29 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.119 -174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.99 -133.03 1.29 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.872 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.55 102.12 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.101 1.867 . . . . 0.0 109.906 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 HG22 ' HA3' ' A' ' 9' ' ' GLY . 2.9 p -115.39 -16.33 11.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.946 -171.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -98.59 123.69 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.2 m -81.75 153.02 26.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.23 42.98 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.911 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 m -55.39 115.17 2.14 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.673 0.608 . . . . 0.0 110.427 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.99 -25.18 7.2 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.3 p -109.06 151.59 26.18 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 p -126.08 137.04 53.59 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -67.21 116.88 8.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -111.11 129.69 55.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.69 104.66 10.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.1 -38.99 15.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.294 0.569 . . . . 0.0 109.588 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -144.57 166.49 18.35 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.37 -44.05 49.54 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.303 2.002 . . . . 0.0 113.908 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.634 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -101.63 -25.28 13.93 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.762 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -95.49 114.25 25.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.482 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.4 m -123.52 145.81 48.57 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.2 tt0 -137.25 140.63 41.78 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.595 0.634 . . . . 0.0 111.51 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.67 116.36 17.27 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 120.809 0.338 . . . . 0.0 110.215 176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.298 -1.636 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 178.053 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.73 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.684 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -88.35 123.91 33.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.522 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 89.0 p -66.66 160.1 26.24 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.115 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.76 129.48 42.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 80.14 8.69 1.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.314 1.445 . . . . 0.0 112.337 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -87.24 160.1 31.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 175.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.7 tt0 -79.74 106.88 12.09 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.811 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.9 p -80.83 11.76 3.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.07 89.16 1.69 Allowed Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.55 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.12 -174.29 30.26 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.71 114.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.864 0.832 . . . . 0.0 109.273 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.44 -10.6 53.97 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.629 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -98.48 106.4 18.67 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -110.43 17.12 21.14 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.462 0.649 . . . . 0.0 111.634 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.79 -141.1 3.94 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.47 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.9 Cg_endo -66.6 109.42 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.904 1.736 . . . . 0.0 112.039 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.2 p -104.76 -21.26 13.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.974 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.91 114.51 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.52 159.79 32.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.469 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.49 151.09 33.78 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.035 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -61.84 115.94 4.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.298 0.571 . . . . 0.0 110.23 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.09 -15.76 20.72 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -109.25 144.22 37.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 p -117.73 134.53 54.81 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -66.93 108.16 2.48 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.163 0.506 . . . . 0.0 110.025 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -104.49 115.25 30.03 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.48 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.61 107.9 14.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.8 mt -90.26 -54.09 4.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.553 0.692 . . . . 0.0 109.855 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -117.45 168.22 9.53 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.97 -37.9 95.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.985 1.79 . . . . 0.0 112.221 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 66.5 m-85 -104.37 -25.76 12.71 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.248 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CE2' HD12 ' A' ' 28' ' ' LEU . 41.6 t80 -95.26 115.06 26.93 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -125.54 144.35 50.6 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 176.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.6 tt0 -137.04 136.52 38.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 119.001 0.819 . . . . 0.0 112.04 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.811 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.6 m -77.62 115.72 17.6 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.4 mt . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.523 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.684 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.431 -1.377 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.5 tp-100 -84.68 128.67 34.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 122.577 0.351 . . . . 0.0 110.173 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -72.81 173.09 9.62 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.564 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -68.57 133.0 47.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 81.94 11.92 0.66 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.718 1.207 . . . . 0.0 113.149 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.38 160.98 20.57 Favored Glycine 0 C--O 1.247 0.952 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.779 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.8 tt0 -75.46 113.7 13.17 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.989 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.883 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -85.72 14.72 5.46 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.99 95.51 0.75 Allowed Glycine 0 CA--C 1.479 -2.201 0 C-N-CA 118.532 -1.794 . . . . 0.0 113.126 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.8 -177.95 29.46 Favored Glycine 0 N--CA 1.414 -2.775 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 78.0 mt -74.8 109.8 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.59 4.26 52.53 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.858 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -94.04 135.54 35.29 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 p -124.03 0.47 8.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.27 -146.65 5.23 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.293 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 37.6 Cg_endo -71.6 113.06 3.52 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.564 2.176 . . . . 0.0 113.381 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -100.3 -21.18 15.55 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.062 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.93 127.14 42.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 60.6 m -85.0 152.38 23.49 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.329 0.393 . . . . 0.0 111.552 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 161.49 25.85 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.148 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 m -56.71 119.24 5.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.401 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.13 -2.14 35.25 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.436 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 77.5 p -126.15 152.72 45.57 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.168 -0.607 . . . . 0.0 110.819 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -124.24 143.86 50.29 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 122.531 0.332 . . . . 0.0 110.143 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.62 106.86 11.96 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -99.62 114.32 27.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.36 94.65 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.59 -41.64 45.5 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.644 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -138.23 165.49 32.85 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.01 -39.35 79.72 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.656 2.237 . . . . 0.0 113.557 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CD1' ' HB ' ' A' ' 11' ' ' ILE . 45.3 m-85 -103.68 -25.91 12.97 Favored 'General case' 0 C--O 1.214 -0.773 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 50.1 t80 -96.08 115.14 26.97 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 41.8 m -120.11 137.55 54.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 64.2 tt0 -133.46 136.5 45.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 119.171 0.896 . . . . 0.0 111.609 -176.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -79.38 109.88 14.14 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.322 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.59 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.82 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 2.9 tp60 -111.24 129.86 55.84 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.169 0.587 . . . . 0.0 110.043 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.453 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 56.5 p -75.75 170.59 15.9 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.915 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.29 134.54 57.16 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.531 1.132 . . . . 0.0 109.69 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 75.15 6.04 4.22 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.797 1.239 . . . . 0.0 113.483 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.99 153.28 23.53 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.2 tt0 -71.13 112.35 7.21 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -90.92 12.49 19.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.62 90.57 1.83 Allowed Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 118.261 -1.923 . . . . 0.0 113.685 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.84 179.39 31.41 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 170.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' TYR . 71.7 mt -59.25 115.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 118.248 1.024 . . . . 0.0 109.951 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 -12.69 49.12 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -97.04 120.58 37.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -120.63 22.8 11.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.22 0.534 . . . . 0.0 111.92 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.48 -141.23 5.06 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.74 108.0 1.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.875 1.717 . . . . 0.0 111.163 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 p -102.63 -22.59 13.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.748 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.74 114.91 28.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 m -75.84 148.52 38.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.395 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.82 58.0 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 m -60.48 125.98 25.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.43 0.633 . . . . 0.0 110.298 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.16 -17.46 9.11 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -172.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.1 p -126.78 151.83 47.73 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.8 p -123.87 145.0 49.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 117.866 0.303 . . . . 0.0 110.234 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.0 115.38 12.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -104.46 115.98 31.32 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 103.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.71 -47.43 8.25 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.239 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.67 171.23 9.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.26 -41.1 53.42 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.534 1.489 . . . . 0.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 45.7 m-85 -101.67 -25.8 13.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.237 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -95.57 114.83 26.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -127.29 142.19 51.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -136.1 138.22 41.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 118.647 0.658 . . . . 0.0 111.673 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.5 m -76.54 116.47 17.25 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.743 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.82 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.759 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.2 tp60 -92.02 120.8 33.0 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.149 0.499 . . . . 0.0 110.966 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.511 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 89.7 p -63.36 159.94 17.11 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.359 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.72 128.98 39.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.07 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 80.68 8.9 1.2 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.044 1.338 . . . . 0.0 112.926 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.59 152.01 24.74 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.151 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.4 tt0 -70.78 108.99 4.71 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.819 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -84.0 8.88 13.84 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 107.8 102.92 2.82 Favored Glycine 0 N--CA 1.423 -2.199 0 C-N-CA 119.504 -1.331 . . . . 0.0 114.79 174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.29 -166.55 28.84 Favored Glycine 0 N--CA 1.427 -1.931 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.457 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 80.1 mt -63.28 116.41 3.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 117.701 0.75 . . . . 0.0 109.83 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.29 -22.31 31.27 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.685 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CD2' ' HA2' ' A' ' 9' ' ' GLY . 20.8 t80 -99.87 104.96 16.65 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 m -116.54 17.67 15.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -125.49 0.54 Allowed Glycine 0 C--O 1.24 0.524 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.94 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.83 101.68 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.382 2.055 . . . . 0.0 111.332 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' HA3' ' A' ' 9' ' ' GLY . 10.7 p -111.58 -20.3 12.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.836 -1.074 . . . . 0.0 112.094 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.1 t -90.09 114.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 62.4 m -78.74 154.12 30.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.016 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 166.31 13.62 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.065 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.4 m -60.11 119.62 8.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.107 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.09 45.08 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.084 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.6 p -118.05 150.13 39.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.374 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 139.79 53.09 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.354 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 t -74.52 107.45 6.66 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -104.71 114.1 28.11 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 99.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.18 -35.3 36.62 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.488 0.661 . . . . 0.0 110.972 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 32.3 m-80 -144.12 165.55 23.41 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.81 -33.99 83.35 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.386 2.058 . . . . 0.0 113.536 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 59.3 m-85 -109.46 -25.92 10.25 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.441 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.5 t80 -95.28 114.24 26.0 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.088 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.4 m -125.65 144.21 50.69 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -137.3 138.59 40.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 118.792 0.724 . . . . 0.0 112.126 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 59.1 m -77.02 107.65 9.52 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.411 -2.408 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.782 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.759 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.9 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 3.4 tp60 -97.43 119.54 36.17 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.499 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 71.4 p -69.21 177.75 2.62 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.649 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -67.66 134.29 50.87 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 78.89 -0.1 2.42 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.213 1.405 . . . . 0.0 113.261 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.57 150.61 29.99 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.967 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.6 tt0 -79.12 114.73 18.3 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 15.1 p -72.06 -43.97 64.06 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.616 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 156.21 107.25 0.26 Allowed Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 119.002 -1.57 . . . . 0.0 113.594 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.38 -161.54 29.24 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.51 114.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 117.161 0.48 . . . . 0.0 110.89 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.08 3.02 65.85 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.649 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 30.2 t80 -99.37 115.52 29.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -109.14 25.1 12.19 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.59 -153.23 29.41 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.64 107.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.354 2.036 . . . . 0.0 111.6 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 23.2 p -95.14 -28.02 15.27 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -82.68 121.31 35.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 55.8 m -80.32 161.35 25.11 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.485 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 162.72 29.05 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.245 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.5 p -60.84 122.83 15.83 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.44 1.49 50.4 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.023 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.0 p -132.02 145.77 51.65 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.222 0.511 . . . . 0.0 110.465 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 p -125.23 132.44 52.97 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.4 t -75.63 115.53 15.4 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.649 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -100.9 122.42 43.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.99 100.36 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD22 ' A' ' 29' ' ' ASN . 85.9 mt -85.7 -41.26 15.3 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.383 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -132.84 163.41 51.1 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.49 -32.86 97.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 121.854 1.703 . . . . 0.0 112.086 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 12.4 m-85 -99.95 -26.75 13.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.614 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE1' HD12 ' A' ' 28' ' ' LEU . 31.4 t80 -96.25 114.26 25.93 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.876 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.5 m -132.23 119.71 21.2 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -118.36 135.07 54.54 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 59.6 m -75.09 110.35 9.33 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.945 0.402 . . . . 0.0 110.61 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.769 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.9 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.696 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -82.32 124.95 30.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.459 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 55.7 p -77.55 171.07 15.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.336 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.77 130.59 47.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.242 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 76.38 12.67 2.6 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.863 1.265 . . . . 0.0 113.15 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.76 160.45 21.75 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.7 tt0 -76.77 110.42 11.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.099 0.476 . . . . 0.0 110.7 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.846 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.5 p -89.16 9.98 23.62 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.1 90.81 1.64 Allowed Glycine 0 N--CA 1.423 -2.167 0 C-N-CA 118.271 -1.919 . . . . 0.0 113.961 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.51 -171.36 30.57 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 170.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 76.4 mt -64.36 123.19 16.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.02 -2.47 61.63 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.398 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -113.86 117.77 32.34 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 m -118.14 11.23 13.2 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.71 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.21 -143.09 2.08 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.36 -0.689 . . . . 0.0 112.474 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.26 105.61 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.1 p -99.87 -23.32 14.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.135 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -83.83 117.89 30.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -80.97 160.04 24.73 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.886 0.741 . . . . 0.0 110.88 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.15 149.24 33.38 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.151 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 t -63.45 120.84 12.44 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.21 17.61 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.5 p -110.76 143.65 40.94 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -118.11 143.11 46.74 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.764 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.7 t -73.48 108.13 6.17 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.167 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -102.99 112.46 25.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.82 100.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.19 -35.59 25.36 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.524 0.678 . . . . 0.0 110.084 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -140.94 164.84 33.48 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.48 -39.73 86.6 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 0.0 113.109 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.623 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.5 m-85 -103.26 -26.56 12.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.348 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 53.6 t80 -96.03 114.21 25.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.925 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -121.35 137.42 54.71 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 33.6 tt0 -129.6 136.93 50.38 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 118.581 0.628 . . . . 0.0 111.337 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.846 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.8 m -77.63 114.58 16.62 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.866 0.365 . . . . 0.0 110.312 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 C--N 1.292 -1.908 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.77 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.696 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.721 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -73.27 128.01 34.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 83.6 p -72.97 166.32 23.28 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.184 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -65.45 131.24 45.91 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 79.1 8.49 1.88 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.487 1.115 . . . . 0.0 112.122 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -85.01 160.96 35.69 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 33' ' ' SER . 45.4 tt0 -79.47 106.89 11.82 Favored 'General case' 0 C--O 1.205 -1.265 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 13.6 p -78.53 5.73 10.21 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -170.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.19 85.99 1.0 Allowed Glycine 0 N--CA 1.417 -2.622 0 C-N-CA 118.515 -1.802 . . . . 0.0 113.027 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.86 -178.74 32.03 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 67.2 mt -60.19 111.73 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 117.377 0.588 . . . . 0.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.09 -19.5 34.85 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.982 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -83.76 112.81 20.42 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -110.16 10.32 23.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.38 -142.87 5.0 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.594 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 32.8 Cg_endo -66.99 109.41 1.7 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.478 2.118 . . . . 0.0 112.599 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.84 -30.56 11.2 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.249 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -79.69 114.81 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.97 150.89 40.49 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.031 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.1 151.85 45.99 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.873 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.9 m -48.96 116.16 1.55 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 124.431 1.093 . . . . 0.0 111.609 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.48 -16.64 21.67 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.982 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -118.17 148.66 42.13 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 122.489 -0.418 . . . . 0.0 110.336 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -129.53 150.99 50.63 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.368 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.98 111.88 6.7 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.932 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -102.64 115.77 31.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.8 95.34 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.21 -48.61 33.66 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.138 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.58 167.21 23.96 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.82 -41.25 71.56 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.175 1.917 . . . . 0.0 113.301 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.632 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 51.6 m-85 -105.85 -26.41 11.75 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.601 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -95.59 114.83 26.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.924 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.5 m -126.04 145.44 50.31 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.5 tt0 -137.19 138.61 40.39 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 119.236 0.926 . . . . 0.0 112.738 -174.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 62.9 m -78.42 114.81 17.65 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--N 1.289 -2.023 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.406 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.721 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' OE1' ' H5 ' ' A' ' 101' ' ' BGC . 6.6 tp-100 -68.74 126.07 28.57 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.181 0.592 . . . . 0.0 110.379 -175.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 60.7 p -75.41 170.62 15.75 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.367 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.67 132.27 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 79.19 0.06 2.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.225 1.41 . . . . 0.0 113.086 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.51 151.23 30.77 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.663 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.2 tt0 -67.75 111.58 4.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.81 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.9 p -89.45 6.4 40.98 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.17 72.83 0.21 Allowed Glycine 0 CA--C 1.477 -2.291 0 C-N-CA 117.537 -2.268 . . . . 0.0 113.434 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.41 168.64 21.98 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 171.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 82.6 mt -59.83 122.0 8.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 118.048 0.924 . . . . 0.0 110.295 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.51 -3.24 32.6 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.449 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -108.1 123.45 48.72 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.346 -0.502 . . . . 0.0 109.751 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 m -117.46 22.7 12.26 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.249 0.547 . . . . 0.0 110.898 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.1 -160.3 27.4 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-O 119.321 -0.71 . . . . 0.0 111.865 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.99 123.6 14.25 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.41 2.74 . . . . 0.0 112.02 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 p -107.02 -26.25 11.24 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.366 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.87 118.03 25.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -74.16 159.22 32.85 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.346 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 160.75 31.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.677 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -58.84 125.59 24.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.591 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.71 -12.52 56.47 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.883 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -122.46 149.9 43.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.423 -0.457 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 p -127.17 146.34 50.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.51 118.53 11.66 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.727 0.299 . . . . 0.0 110.23 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -104.51 120.65 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.94 98.81 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -83.44 -38.23 22.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.703 0.763 . . . . 0.0 109.756 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -142.74 164.1 34.57 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.06 -32.78 96.28 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.85 1.7 . . . . 0.0 112.406 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 41.6 m-85 -105.75 -26.48 11.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.578 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -97.05 114.68 26.34 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.67 142.64 51.48 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -139.56 138.03 35.9 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.604 0.638 . . . . 0.0 111.803 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.9 m -75.72 113.97 13.78 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.91 0.386 . . . . 0.0 111.362 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.299 -1.598 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.678 ' H5 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.629 ' OE1' ' H3 ' ' A' ' 101' ' ' BGC . 6.4 tp-100 -89.08 122.18 32.14 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' C1 ' ' A' ' 101' ' ' BGC . 87.0 p -68.38 168.34 12.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.0 112.857 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -66.12 129.82 41.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 80.51 5.16 1.68 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.485 1.514 . . . . 0.0 112.772 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -88.6 169.34 37.2 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -85.11 112.14 20.4 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-O 121.197 0.523 . . . . 0.0 110.711 -177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.814 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.7 p -95.07 20.59 8.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -172.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.99 80.31 1.04 Allowed Glycine 0 CA--C 1.488 -1.604 0 C-N-CA 118.085 -2.007 . . . . 0.0 114.934 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.89 -178.08 32.06 Favored Glycine 0 C--N 1.294 -1.762 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.26 117.19 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.59 0.695 . . . . 0.0 110.163 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.39 -31.72 8.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.021 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -92.15 104.7 17.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.302 0.572 . . . . 0.0 109.651 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -113.37 27.58 9.47 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.247 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.79 -138.29 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.133 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -68.29 102.72 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 119.186 1.493 . . . . 0.0 110.459 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -100.1 -22.46 15.19 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.693 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.8 t -82.43 121.66 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.6 m -80.54 155.99 26.7 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.94 153.24 8.95 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.153 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -56.91 112.38 1.31 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.571 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.77 -8.32 31.87 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.22 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -117.16 147.44 42.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.896 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 p -123.73 144.06 49.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -72.6 115.59 12.05 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.594 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -103.52 126.79 50.88 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.1 103.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 32' ' ' TYR . 89.5 mt -85.65 -50.91 6.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.745 0.783 . . . . 0.0 109.124 -176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -122.84 163.55 32.38 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 104.291 -2.485 . . . . 0.0 104.291 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.87 -34.98 95.21 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.311 1.341 . . . . 0.0 111.739 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.553 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 4.8 m-85 -99.94 -26.69 13.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.546 -0.861 . . . . 0.0 110.993 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 46.6 t80 -96.55 114.16 25.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.811 -0.756 . . . . 0.0 112.853 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -121.01 142.06 50.15 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 34.8 tt0 -133.65 135.9 44.43 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.41 0.55 . . . . 0.0 111.68 -175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -76.41 116.73 17.37 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' BGC . . . . . 0.629 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_